Please login to the form below

Not currently logged in
Email:
Password:

Ian Weatherhead joins Ipsen

Takes up corporate communications role at the French pharma firm

Ipsen Dr Ian WeatherheadFrench biopharmaceutical company Ipsen has appointed Ian Weatherhead as vice president, corporate external communications.

He brings 20 years of corporate communications experience within the life sciences sector, most recently at Teva UK/Ireland where he led its corporate communications and government affairs team.

Prior to that he held global, regional and affiliate roles with AstraZeneca, Syngenta, UCB and Sanofi.

In his new role at Ipsen Weatherhead will be responsible for the design and implementation of an external corporate communications strategy.

Reporting to senior vice president, public affairs and

corporate communications Didier Veron, Weatherhead will also oversee Ipsen’s media and public relations, digital communications, and corporate image and reputation.

Veron said: “I am delighted that Ian is joining the team to advance our external communications strategy as Ipsen continues its evolution into a leading global biopharmaceutical company focused on innovation and specialty care. He brings a wealth of experience in the pharmaceutical sector.”

13th September 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics